🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the service has removed problematic content and prohibited related hashtags and search suggestions. The company said it was committed to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with images of slimming results, positive reviews and detailed guides for preparing or injecting at residence.

Within moments of joining one community, a seller posted contact information, where most purchases take place. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.

Item Information and Costs

Within these communities, posts display black plastic packages with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for Telegram stated it actively monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to potentially significant medical dangers”.